Omaveloxolone + Mao Inhibitors Interaction
Majorinteraction on record
Description
Concomitant use results in clinically significant increased exposure of omaveloxolone, which may increase the risk of adverse reactions. Avoid concomitant use; if unavoidable, dosage reduction with monitoring is recommended.
Mechanism
CYP3A4 inhibition increases omaveloxolone exposure
Source: NLP:omaveloxolone